Weitz & Luxenberg Attorney Plays Key Part in the Negotiation Monsanto has agreed to pay up to $300 million to soybean producers and additional amounts…
Read MoreFirm News: Feb. 2017
Category: Drugs & Devices
W&L Investigates Rising Costs of Insulin
Weitz & Luxenberg is investigating the pricing of insulin by three major drug companies — Eli Lilly, Novo Nordisk, and Sanofi — following a…
Category: Our Firm
W&L Secures Pro Bono Decision Limiting Solitary Confinement for Death Row Inmates Who Have Been Granted New Sentences
Weitz & Luxenberg has secured a decision in the U.S. Court of Appeals for the Third Circuit that recognizes a constitutionally protected liberty interest…
Category: Drugs & Devices
Zimmer Biomet Recalls Comprehensive Reverse Shoulder, Cites High Fracture Rate, says FDA
Weitz & Luxenberg is currently accepting cases from people harmed by a faulty shoulder replacement device made by Zimmer Biomet.The medical device manufacturer issued…
Category: Drugs & Devices
Nurse Assist IV Syringes Linked to Dangerous Infections
Weitz & Luxenberg is currently accepting cases from people who became seriously ill or who had relatives die after they developed bloodstream infections due…
Category: Our Firm
W&L Of Counsel Attorney Ellen Relkin to Participate in Three Legal Seminars in Three Months
Weitz & Luxenberg of counsel attorney Ellen Relkin will partake in three legal seminars — all within a three-month period.Relkin’s first speaking engagement is…